kicker.cloud provides end-to-end project management software for complex projects, such as M&A and private investments. Covering target tracking, project execution, and value creation / integration, the platform helps users improve efficiency, reduce operational risk, and drive scalable operations within organisations. All data is integrated, allowing companies to take their data re-usage, automation, and analytics to the next level for enhanced insights and decision making. The solution is looking to revolutionise the finance sector, with applications and ambitions far beyond.

BitPet is an AR multiplayer mobile game making physical activity fun and social. Each player has a pet whose health depends on the activity from their step counter, and players can meet each other's pets in multiplayer AR which is fun and social. The idea for the game is based on research by a professor of game technology and co-founder of Kahoot! The game is currently in early beta and will be launched commercially in 2023.

We enable the green shift to happen in new markets! TioTech is a Norwegian producer of titania (TiO2) nanomaterials and a developer of titania-based technology. We know how to optimise the production process and properties of titania nanoparticles. After successfully developing and commercialising a series of photocatalytic surface treatment products (www.joma-int.com), we are directing our R&D efforts towards a new area; the use of titania as anode-material in Lithium-ion batteries (LIB). A battery with our material on the anode will charge faster, last longer, be safer and tolerate temperature variation better than conventional batteries which have graphite on the anode, and outcompete LTO-batteries on capacity. The development work takes place in our in-house laboratory in Bergen, where our dedicated team (Hjørdis, Marthe, Rob, Anders) play around with titania, giving life to innovative solutions.

We invest in our planet. Norselab is a leading Nordic impact investment platform based out of Oslo, Norway. With an uncompromising focus on creating a meaningful future for all, we invest in net-positive companies that accelerate the urgently needed change in global industries. Norselab currently manages four funds; three venture funds and one credit fund. The ambition is to expand rapidly across classes and investment phases thanks to its pioneering impact approach, first-rate investment teams, and institutional-grade governance rig. Norselab is backed by Capricorn Investment Group, one of the largest mission-aligned investment firms in the world. To learn more about Norselab, visit norselab.com or get in touch at hello@norselab.com. Are you looking for meaningful capital to fund your company? We're always curious to hear from ambitious companies with a meaningful core. Submit the form on this page to open a discussion with us: http://norselab.com/dealflow.

We have developed a camera-based sensor for 24h automatic sea lice counting and biomass measurement. Our product solves the main challenges in high contrast underwater imagery of sea lice with deficient maintenance. We are looking for funding to take the effect to the next level, where approval of our solution in the industry and by authorities are key factors as well as the development of the organization.

Iterate is an ecosystem for digital innovation, and we like to describe ourselves as a company that builds companies. We contribute from A-Z when building, starting with creating concepts based on key insights to launching and improving products whilst living in the marketplace. We find the right team and work toward the company culture that enables us to deliver value to our customers quickly. The key to achieving this is reinvesting all our profits in the ideas of our employees, or selected entrepreneurs. Five years into this strategy, we own shares in fifteen ventures; all of which are showing promising results. Our 70 designers, developers, and product managers just moved into new locations in the center of Oslo. 
Close collaboration with our customers is key to our success. They provide domain know-how, and we provide tools, strategies, and experts. Together we uncover the best way that connects your strategy and idea with the market needs. Our goal is to achieve minimum risk and give our customers the best possible starting point for scaling, on their own, or in continued collaboration.

RESPINOR is a privately-owned medical device company, founded in Oslo, 2015. We have developed an objective measure of breathing for critically ill patients within intensive care. The technology provides precise, continuous and real-time information of diaphragm function, our main breathing muscle, to increase the quality of care and reducing costs. RESPINOR’s technology is the winner of Horizon 2020 both in phase I and II. We are addressing an unmet medical need because every breath counts.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Excitus is set up to develop, manufacture and sell medical suction products based on its revolutionary, patent-pending mobile suction platform. Products will span from professional hand-held tools for paramedics to consumer devices in a private home and stored together with the defibrillator at supermarkets, stadiums, etc. The platform enables a higher survival rate at cardiac arrests, yet at the same time, it provides a razor/razorblade business model unseen in this area.

CYBERSECURITY FOR INDUSTRIAL NETWORKS AND CONTROL SYSTEMS Secure-NOK® is a technology company providing cybersecurity solutions for monitoring industrial networks (OT), and for detecting vulnerable areas. The company has vast experience and recognized technology, and has participated in several research projects with outstanding results. The technology (SNOK) can detect any abnormal event in a network and prevent important infrastructure from experiencing downtime due to malicious attack. Today, most industries are digitized, and thus more exposed to attacks from the outside. With technology from Secure-NOK, such attacks will be detected early, and thus avoid damage and downtime. Secure-NOK has developed patented sensors which are installed in a OT network, and which capture and report any abnormal traffic. The company has sensors for both networks, end-stations and PLC systems.

Software is eating education. Technology is used to modernise education. TERP has redefined the concept of a book by making it interactive. In its easiest form interaction can be films and animations integrated in a book. Tests and feedback on learning is one step further. In its most complex form, interaction is customised books generated for each reader, based on mapped preferences used as input in algorithms. The first book using this technology will have 114,000 potential versions. The TERP technology is not only redefining the concept of a book. It is interrupting the value chain in the industry. The technology provides a new and dynamic way of distribution. Competitors trying to copy the technology, not only has to figure out the code, they must change the way of doing business.

We are disrupting heavy construction. They build roads and infrastructure for billions of NOK/USD/EUR. But paper and old-school applications are still the things when it comes to data collection and reporting. We have cracked some of the code and have landed contracts with some of the biggest construction companies in the world. Are you the kind of person that would like to join a startup in the beginning? Take charge of your field, and help us become the global leader that we have the potential to be. All that stands between us and international success is us - and you. Can we execute well enough? We have a base product. The market has already accepted us. Do you want to join the core team? Reach out to us! We are especially on the lookout for the following areas. But please reach out if you think you have anything of value to us! - UX / front-end (future stack is react-based, you will help us mold it) - Native gurus (iOS/Android)

VesselMan is a cloud-based management system that enables the digitalization of your value chain .​Digitalization by Vesselman enables improved "ways of work” with closer partnership and distributed value chains, lean processes, and self-service operations that reduce risks, costs, and people dependency.  We help ship owners and ship managers to digitalize the execution of complex dry-docking, conversion, and new building projects by providing a cloud-based management system that is easy to use and easy to implement. We also provide intelligent apps for digital collaboration, ISM safety, asset management, and utilization of IoT and big data. We have signed several well know customers and have recently signed a partnership with Kongsberg Digital in order to take part in their Kognifai platform.

M2Call Aps is a MedTech company that delivers innovative software solutions for the healthcare sector using AI technology. We are on a critical mission to optimize manual tasks and workflows, empower healthcare personnel to make clinical decisions based on clinically relevant information, and ultimately ensure that patients receive safer care today and in the future.

XYZ Enterprises is developing BetterCity to help cities improve urban quality and tackle climate change by leveraging other cities. The What: There are about 1 million city governments globally. Cities are faced with budget constraints and spend a lot of money on research to improve decision making. Information about other cities and solutions is dynamic and always changing, but research projects are static. The How: BetterCity is SaaS platform to help cities improve urban quality and tackle climate change by leveraging other cities. The BetterCity platform will include city profiles with information such as: • % of travellers using each type of transportation • Car sharing and micromobilty services • EV charging • Parking • Related pricing for travelers • Related legislation • Projects Advantages to cities: • Make better decisions • Save money • Cooperate and compete with other cities The Why: Our mission is to help transform cities on a global scale to improve urban quality and help tackle climate change.